-
General Overview of Drug Reference Materials (1
Time of Update: 2022-06-24
The 1985 edition of the "Chinese Pharmacopoeia" included 76 chemical reference substances and reference medicinal materials in the standard for the first time.
-
FDA grants Bayer's oral FXIa inhibitor asundexian Fast Track designation
Time of Update: 2022-05-03
asundexian is an oral factor XIa (FXIa) inhibitor currently being developed as a potential drug for secondary prevention in patients with NCIS, as well as 2 other diseases: atrial fibrillation (irregular heartbeat) and recent myocardial infarction (heart attack) .
-
The 15 batches of unqualified food in Shaanxi were notified to involve four categories of edible agricultural products, beverages, condiments, and fruit products
Time of Update: 2022-04-21
In addition, 2 batches of perch were unqualified, namely: 1 batch of live perch (fresh water) sold by Jixiang Frozen Aquatic Products Distribution Department in Weibin District, Baoji City, malachite green was found to be inconsistent with the "Prohibited Drugs in Food Animals".
-
Nature Aging: Discovering new Alzheimer's disease targets in brain senescent cells
Time of Update: 2021-12-29
Wake Forest School of Medicine"However, until now, we did not know to what extent senescent cells accumulate in the human brain and what they actually look like," Orr said .
The research team concluded that CDKN2D/p19 expressing neurons with NFTs represent a unique cell population with an senescence-like phenotype in human Alzheimer's disease .
-
The competitive landscape of the innovative drug industry is facing reconstruction, and FIC drugs are more favored by capital
Time of Update: 2021-11-14
Also in September, Yinming Bio, which is committed to the research and development of first-in-class drugs with global competitiveness, announced the completion of nearly US$50 million in A+ round of financing .
-
The UK takes the lead in approving the use of Merck's oral anti-corona drug
Time of Update: 2021-11-11
The British Medicines and Health Products Administration issued a communiqué on the 4th that monabiravir has been approved for use in patients with mild to moderate symptoms of new coronary disease.
-
The first in China! Mabotech submits omalizumab biosimilar drug listing application
Time of Update: 2021-11-03
In addition, Novartis applied for the marketing of omalizumab injection (acceptance number: JXSS2101002/3) on April 10 this year, after treatment with inhaled glucocorticoids and long-acting inhaled β2-adrenergic receptor agonists , Still can not effectively control the symptoms of moderate to severe persistent allergic asthma .
-
The latest "prescription drugs sold online" policy: 5 types of preparations cannot be sold online
Time of Update: 2021-08-14
In 2018, the "Measures for the Supervision and Administration of Drug Online Sales (Draft for Comment)" stated that online drug sellers who are drug retail chain enterprises shall not sell prescription drugs and drugs with special management requirements by the state through the Internet; sell to individual consumers Drug websites must not publish prescription drug information via the Internet .
-
Pharmaceutical companies sued the State Food and Drug Administration to win
Time of Update: 2021-08-12
The original review decision made an error in citing the "Regulations on the Administration of Drug Technology Transfer Registration", and the reason for not approving the supplementary application for the drug involved in the case was untenable .
-
Food Safety Supervision and Sampling Inspection Information Announcement of Zhejiang Provincial Market Supervision Administration (No. 17 of 2021
Time of Update: 2021-06-21
(2) The mantis shrimp and cadmium (calculated as Cd) sold at the Zhang Yangquan stall in the central farmer's market in Zhili Town, Huzhou City did not meet the national food safety standards .
-
Shanghai Pharmaceuticals SPH3127 Tablets New Indication Approved for Clinical Clinic
Time of Update: 2021-06-02
On May 19, Shanghai Pharmaceuticals issued an announcement stating that the clinical trial application for the development of "SPH3127 tablets" for chronic kidney disease indications was officially accepted by the State Food and Drug Administration.
-
The Standing Committee of the National People's Congress on authorizing the State Council to carry out drug market licensing in some places
Time of Update: 2021-02-02
The State Administration of Food and Drug Administration shall formulate a specific pilot program and report it to the Standing Committee of the National People's Congress for the record after approval by the State Council.
-
Notice of Food Safety Supervision and Sampling Information of Zhejiang Market Supervision Administration (No. 1 of 2021
Time of Update: 2021-01-14
According to the national standards of food safety inspection and determination: sampling inspection qualified 525 batches, unqualified 13 batches (see annex), non-conforming items related to microbial pollution, agricultural and veterinary drug residues exceeded the standard, food additives exceeded the standard, quality indicators are not up to standard.
-
Baby intestinal colic is where the monster, actually let Bao parents so headache
Time of Update: 2020-08-11
if your baby is fed with formula, do not rule out formula allergy or intolerance leading to the appearance of intestinal colic, in this case it is recommended to go to the hospital for professional help, under the guidance of a doctor can choose to try to use 1 week of deep hydrolyzed infant formula.
-
Nature Comment . . . Zebutini's registration and approval process differences
Time of Update: 2020-08-09
On July 10, , Nat Rev Clin Oncol (Impact Factor 53.28) published an article by the Chen Xiaoxuan Research Team at Tsinghua University outlining the regulatory process and review considerations of Zebutinib by The Chinese and American drug regulators, discussing potential ways for China and other countries to simultaneously review the approval of drugs.
